Financial Resources —Did you know that there are many financial resources that can help people living with breast cancer? Find out more
Rally for the Cure — Golf, tennis, dinner events and so much more...
Go Passionately Pink to help save lives! — Just wear pink, have fun and raise money to fight breast cancer. Be inspired by the multitude of ideas right here, or think of your own. There are so many creative ways to have fun and fight breast cancer.
Case Western Reserve University Receives Research Grant
CASE WESTERN RESERVE RESEARCHERS TO INVESTIGATE WHY OLDER BREAST CANCER PATIENTS OFTEN DON’T RECEIVE EQUAL LEVELS OF CARE, THANKS TO FUNDS FROM SUSAN G. KOMEN FOR THE CURE®
World’s Largest Breast Cancer Organization Investing Nearly $7 Million into Ohio’s Economy for Research and Community Programs
CLEVELAND, OH. – July 13, 2010 – While breast cancer mortality rates are declining among women younger than 70 years of age, they are either stable or increasing among the oldest old women with the disease, and researchers from Case Western Reservice University School of Medicine intend to find out why with a research grant announced today by Susan G. Komen for the Cure®, the global leader in the breast cancer movement.
The $450,000 grant is one of three totaling more than $800,000 that Komen for the Cure is investing in Ohio for breast cancer research this year, and is part of a $59 million portfolio of 2010 research grants that Komen is distributing worldwide to find cures for breast cancer.
Case Western Reserve researchers say their research could lead to better personalized treatments for both stronger and weaker older patients.
“We’ve made huge progress in 30 years against this disease for many different women,” said Ambassador Nancy G. Brinker, founder and CEO of Susan G. Komen for the Cure. “It’s definitely time to focus our attention and resources toward the treatment of our older breast cancer patients.”
“Komen’s infusion of millions of dollars into research projects means that promising research that is designed to treat and ultimately eradicate breast cancer will continue,” said Eric Winer, M.D., Komen’s chief scientific advisor.
![]() |